The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–518 of 518
Yurkovetskiy, A., & Fram, R. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.007 · Cited by 100
Ali‐Boucetta, H., Al‐Jamal, K. T., Müller, K. H., Li, S., Porter, A. E., Eddaoudi, A., Prato, M., Bianco, A., & Kostarelos, K. (2011) · Small · doi:10.1002/smll.201101004 · Cited by 100
Visser, C. C., Stevanović, S., Voorwinden, L. H., Gaillard, P. J., Crommelin, D. J. A., Danhof, M., & de Boer, A. G. (2004) · Journal of drug targeting · doi:10.1080/10611860410001701706 · Cited by 98
Kottschade, L. A., Suman, V. J., AMATRUDA, T. T., McWilliams, R. R., Mattar, B. I., Nikcevich, D. A., Behrens, R. J., Fitch, T. R., Jaslowski, A. J., & Markovic, S. N. (2010) · Cancer · doi:10.1002/cncr.25659 · Cited by 98
Mattheolabakis, G., Taoufik, E., Haralambous, S., Roberts, M. L., & Avgoustakis, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.011 · Cited by 98
Polymeric Drug Delivery Systems
(2005) · CRC Press eBooks · doi:10.1201/9780849348129 · Cited by 98
Chen, H., Gao, J., Lu, Y., Kou, G., Zhang, H., Fan, L., Sun, Z., Guo, Y., & Zhong, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.010 · Cited by 97
Han, X. F., Liu, J., Liu, M., Xie, C., Zhan, C., Gu, B., Liu, Y., Feng, L., & Lu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.035 · Cited by 97
Atyabi, F., Sobhani, N., Adeli, M., Dinarvand, R., & Ghahremani (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17336 · Cited by 96
Cytotoxicity of Paclitaxel Incorporated in PLGA Nanoparticles on Hypoxic Human Tumor Cells
Jin, C. S., Bai, L., Wu, H., Song, W., Guo, G., & Dou, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9889-z · Cited by 95
Garde, S. V., Forté, A. J., Ge, M., Lepekhin, E. A., Panchal, C. J., Rabbani, S. A., & Wu, J. J. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282a213ce · Cited by 94
Development of a Peptide–Drug Conjugate for Prostate Cancer Therapy
Tai, W., Shukla, R., Qin, B. Y., Li, B., & Cheng, K. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200007b · Cited by 94
The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro
Wu, W. Y. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s8503 · Cited by 94
Yang, J. C.-H., Topalian, S. L., Schwartzentruber, D. J., Parkinson, D. R., Marincola, F. M., Weber, J. S., Seipp, C. A., White, D. E., & Rosenberg, S. A. (1995) · Cancer · Cited by 94
The Business of RNAi Therapeutics in 2012
Haussecker, D. (2012) · Molecular Therapy: Nucleic Acids · doi:10.1038/mtna.2011.9 · Cited by 93
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
Boyraz, B., Şendur, M. A. N., Aksoy, S., Babacan, T., Roach, E. C., Kızılarslanoğlu, M. C., Petekkaya, İ., & Altundağ, K. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.775113 · Cited by 91
Dritschilo, A., Huang, C. H., Rudin, C. M., Marshall, J. L., Collins, B., Dul, J. L., Zhang, C., Kumar, D., Gokhale, P. C., Ahmad, A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1260 · Cited by 91
Schlesinger, N., Yasothan, U., & Kirkpatrick, P. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3349 · Cited by 91
Kan, P., Tsao, C.-W., Wang, A.-J., Su, W.-C., & Liang, H.-F. (2010) · Journal of Drug Delivery · doi:10.1155/2011/629234 · Cited by 90
Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice
Moreno, D., Zalba, S., Navarro-Blasco, Í., de Ilarduya, C. T., & Garrido, M. J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.10.005 · Cited by 90
Rudin, C. M., Marshall, J. L., Huang, C. H., Kindler, H. L., Zhang, C., Kumar, D., Gokhale, P. C., Steinberg, J., Wanaski, S., Kasid, U. N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0642 · Cited by 90
Ryan, M. C., Kostner, H., Gordon, K. A., Duniho, S. M., Sutherland, M. K., Yu, C., Kim, K. M., Nesterova, A., Anderson, M. E., McEarchern, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605816 · Cited by 88
Soepenberg, O., Dumez, H., Verweij, J., de Jong, F. A., de Jonge, M. J. A., Thomas, J., Eskens, F. A. L. M., van Schaik, R. H. N., Selleslach, J., ter Steeg, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1758 · Cited by 88
Khan, M. K., Nigavekar, S. S., Minc, L. D., Kariapper, M. S. T., Nair, B. M., Lesniak, W. G., & Balogh, L. P. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400604 · Cited by 88
Use of nanoscale delivery systems to maintain synergistic drug ratiosin vivo
Dicko, A., Mayer, L. D., & Tardi, P. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.538678 · Cited by 86
Dhanikula, R. S., & Hildgen, P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.012 · Cited by 84
Seiden, M. V., Muggia, F. M., Astrow, A., Matulonis, U. A., Campos, S., Roche, M. R., Sivret, J., Rusk, J., & Barrett, E. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.037 · Cited by 84
Chaudhuri, P., Soni, S., & Sengupta, S. (2009) · Nanotechnology · doi:10.1088/0957-4484/21/2/025102 · Cited by 84
Ding, D., Zhu, Z., Liu, Q., Wang, J., Hu, Y., Jiang, X., & Li, R. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.008 · Cited by 84
Gonzalez-Angulo, A. M., Meric‐Bernstam, F., Chawla, S. P., Falchook, G. S., Hong, D. S., Akçakanat, A., Chen, H., Naing, A., Fu, S., Wheler, J. J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3110 · Cited by 82
Oh, K. S., Song, J. Y., Cho, S. H., Lee, B. S., Kim, S. Y., Kim, K., Jeon, H., Kwon, I. C., & Yuk, S. H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.021 · Cited by 82
Design and development of polymer conjugates as anti-angiogenic agents
Segal, E., & Satchi‐Fainaro, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.005 · Cited by 81
Gualberto, A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.641532 · Cited by 81
Tan, D. S. W., Gerlinger, M., Teh, B. T., & Swanton, C. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.019 · Cited by 80
Lu, C. S., Perez-Soler, R., Piperdi, B., Walsh, G. L., Swisher, S. G., Smythe, W. R., Shin, H. J. C., Ro, J. Y., Feng, L., Truong, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.802 · Cited by 79
Pal, A., Khan, S., Wang, Y.-F., Kamath, N., Sarkar, A., Ahmad, A., Sheikh, S., Ali, S., Carbonaro, D., Zhang, A., et al. (2005) · PubMed · Cited by 79
Scott, L. C., Yao, J. C., Benson, A. B., Thomas, A., Falk, S. J., Mena, R. R., Picus, J., Wright, J. R., Mulcahy, M. F., Ajani, J. A., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0746-2 · Cited by 78
Lim, J., Guo, Y., Rostollan, C. L., Stanfield, J., Hsieh, J., Sun, X., & Simanek, E. E. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000292 · Cited by 78
Deeken, J. F., Slack, R. S., Weiss, G. J., Ramanathan, R. K., Pishvaian, M. J., Hwang, J. J., Lewandowski, K., Subramaniam, D. S., He, A. R., Cotarla, I., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2048-y · Cited by 78
Ton, N. C., Parker, G. J. M., Jackson, A., Mullamitha, S., Buonaccorsi, G. A., Roberts, C., Watson, Y., Davies, K. E., Cheung, S., Hope, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1550 · Cited by 78
Synthesis of Water-Soluble Dendrimers Based on Melamine Bearing 16 Paclitaxel Groups
Lim, J., & Simanek, E. E. (2007) · Organic Letters · doi:10.1021/ol7024907 · Cited by 77
Bolling, C., Graefe, T., Lübbing, C., Jankevičius, F., Uktveris, S., Česas, A., Meyer‐Moldenhauer, W., Starkmann, H., Weigel, M. T., Burk, K., et al. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-8221-6 · Cited by 77
Zalipsky, S., Saad, M., Kiwan, R., Ber, E., Yu, N. Y., & Minko, T. (2007) · Journal of drug targeting · doi:10.1080/10611860701499946 · Cited by 77
Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death
Arlt, M., Haase, D., Hampel, S., Oswald, S., Bachmatiuk, A., Klingeler, R., Schulze, R., Ritschel, M., Leonhardt, A., Fuessel, S., et al. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/33/335101 · Cited by 75
Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors
Soepenberg, O., de Jonge, M. J. A., Sparreboom, A., de Bruin, P. C., Eskens, F. A. L. M., de Heus, G., Wanders, J., Cheverton, P., Ducharme, M. P., & Verweij, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.703.11.2 · Cited by 75
Parveen, S., & Sahoo, S. K. (2010) · Cancer Nanotechnology · doi:10.1007/s12645-010-0006-0 · Cited by 74
Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells
Singh, R., Mehra, N. K., Jain, V. K., & Jain, N. K. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.778264 · Cited by 72
Jones, R. J., Hawkins, R. E., Eatock, M. M., Ferry, D. R., Eskens, F. A. L. M., Wilke, H., & Evans, T. R. J. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0486-8 · Cited by 71
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes
Gao, J., Zhong, W. H., He, J., Li, H., Zhang, H., Zhou, G., Li, B., Lü, Y., Zou, H. L., Kou, G., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.018 · Cited by 71
Cirstoiu-Hapca, A., Buchegger, F., Bossy-Nobs, L., Kosinski, M., Gurny, R., & Delié, F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.006 · Cited by 71
Recent progress in nanotechnology for cancer therapy
Tang, M.-F., Lei, L., Guo, S., et al. (2010) · 癌症:英文版 · doi:10.5732/cjc.010.10075 · Cited by 70
Pharmaceutical Polymeric Controlled Drug Delivery Systems
Kumar, M. N. V. R., Kumar, N., Domb, A. J., & Arora, M. (2002) · Advances in polymer science · doi:10.1007/3-540-45362-8_2 · Cited by 70
Polymer-based Oral Peptide Nanomedicines
Pérez‐Herrero, E., Alonso, M. J., & Csaba, N. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.40 · Cited by 69
Self-citationPhase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer
Booser, D. J., Esteva, F. J., Rivera, E., Valero, V., Esparza-Guerra, L., Priebe, W., & Hortobágyi, G. N. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0464-0 · Cited by 67
Liposomes, a promising strategy for clinical application of platinum derivatives
Zalba, S., & Garrido, M. J. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.778240 · Cited by 66
Dinarvand, R., Taheri, Rabbani, Khorramizadeh, M., Borougeni, A. T., Mansoori, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s23949 · Cited by 66
Tippayamontri, T., Kotb, R. R., Paquette, B., & Sanche, L. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9494-3 · Cited by 63
Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives
Riggio, C., Pagni, E., Raffa, V., & Cuschieri, A. (2011) · Journal of Nanomaterials · doi:10.1155/2011/164506 · Cited by 63
Zamboni, W. C., Ramalingam, S. S., Friedland, D., Edwards, R. P., Stoller, R. G., Strychor, S., Maruca, L. J., Zamboni, B. A., Belani, C. P., & Ramanathan, R. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1405 · Cited by 63
Nanoparticle Trojan Horses Gallop From the Lab Into the Clinic
Service, R. F. (2010) · Science · doi:10.1126/science.330.6002.314 · Cited by 63
The Treatment of Breast Cancer Using Liposome Technology
Brown, S., & Khan, D. R. (2012) · Journal of Drug Delivery · doi:10.1155/2012/212965 · Cited by 61
Taheri, A., Dinarvand, R., Atyabi, F., Ghahremani, M. H., & Ostad, S. N. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.016 · Cited by 59
Ly, T. U., Trân, N. Q., Hoang, T. K. D., Phan, K. N., Truong, H. N., & Nguyen, C. K. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2013.1479 · Cited by 59
Wang, F., Cai, X., Su, Y., Hu, J., Wu, Q., Zhang, H., Xiao, J., & Cheng, Y. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.07.031 · Cited by 57
Jain, A., Chashoo, G., Singh, S. K., Saxena, A. K., & Jain, S. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.522257 · Cited by 57
Surface functionalisation of PLGA nanoparticles for gene silencing
Andersen, M. Ø., Lichawska-Cieślar, A., Arpanaei, A., Jensen, S. M. R., Kaur, H., Oupický, D., Besenbacher, F., Kingshott, P., Kjems, J., & Howard, K. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.069 · Cited by 57
Naumovski, L., & Junutula, J. R. (2010) · PubMed · Cited by 56
Polymeric micelles for cancer therapy: 3 C’s to enhance efficacy
Talelli, M., Rijcken, C. J. F., Hennink, W. E., & Lammers, T. (2012) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2012.10.003 · Cited by 55
Ebrahimnejad, P., Dinarvand, R., Jafari, M. R., Tabasi, S. A. S., & Atyabi, F. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.022 · Cited by 53
Fracasso, P. M., Picus, J., Wildi, J. D., Goodner, S. A., Creekmore, A. N., Gao, F., Govindan, R., Ellis, M. J., Tan, B. R., Linette, G. P., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0756-0 · Cited by 52
Payne, M., Ellis, P., Dunlop, D. J., Ranson, M., Danson, S. J., Schacter, L., & Talbot, D. C. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31631-2 · Cited by 52
Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
Hu, & Zhang, Y. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s14753 · Cited by 51
Groves, M. D., Puduvalli, V. K., GILBERT, M. R., Levin, V. A., Conrad, C. A., Liu, V., Hunter, K., Meyers, C., Hess, K. R., & Yung, W. K. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605189 · Cited by 50
Ornes, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314120110 · Cited by 50
Infante, J. R., Keedy, V. L., Jones, S. F., Zamboni, W. C., Chan, E. W., Bendell, J. C., Lee, W., Wu, H., Ikeda, S., Kodaira, H., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1960-5 · Cited by 49
Satouchi, M., Okamoto, I., Sakai, H., Yamamoto, N., Ichinose, Y., Ohmatsu, H., Nogami, N., Takeda, K., Mitsudomi, T., Kasahara, K., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.02.020 · Cited by 49
General aspects of anti-angiogenesis and cancer therapy
Zogakis, T. G., & Libutti, S. K. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.2.253 · Cited by 49
Mueller, C., Al-Batran, S. E., Jaeger, E., Schmidt, B., Bausch, M., Unger, C., & Sethuraman, N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2533 · Cited by 49
Matsuo, H., Wakasugi, M., Takanaga, H., Ohtani, H., Naito, M., TSURUO, T., & Sawada, Y. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00460-6 · Cited by 48
Podesta, J. E., & Kostarelos, K. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)64017-9 · Cited by 45
Kim, T. H., Jiang, H., Youn, Y. S., Park, C. W., Lim, S. M., Jin, C., Tak, K. K., Lee, H. S., & Lee, K. C. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22298 · Cited by 45
Targetable HPMA Copolymer–Aminohexylgeldanamycin Conjugates for Prostate Cancer Therapy
Borgman, M. P., Ray, A., Kolhatkar, R. B., Sausville, E. A., Burger, A. M., & Ghandehari, H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9851-0 · Cited by 44
N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates
Duncan, R. (2005) · CRC Press eBooks · doi:10.1201/9780849348129-4 · Cited by 44
Veltkamp, S. A., Witteveen, E. O., Capriati, A., Crea, A., Animati, F., Voogel-Fuchs, M., van den Heuvel, I. J. G. M., Beijnen, J. H., Voest, E. E., & Schellens, J. H. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0438 · Cited by 43
Pegvisomant in the treatment of acromegaly
Parkinson, C. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00111-x · Cited by 42
Yusuf‐Makagiansar, H., & Siahaan, T. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011007014510 · Cited by 39
Polymeric‐Micelle‐Based Nanomedicine for siRNA Delivery
Liu, X., Sun, C., Yang, X., & Wang, J. (2013) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201200061 · Cited by 39
Du, F., Huang, X., Chen, G.-T., et al. (2010) · Macromolecules · doi:10.1021/ma902227g · Cited by 39
Taheri, A., Dinarvand, R., Atyabi, F., Nouri, F. S., Ahadi, F., Ghahremani, M. H., Ostad, S. N., Borougeni, A. T., & Mansoori, P. (2011) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2011.1340 · Cited by 38
Progress in siRNA Delivery Using Multifunctional Nanoparticles
Gao, W., Xiao, Z., Radovic-Moreno, A., Shi, J., Langer, R., & Farokhzad, O. C. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-657-3_4 · Cited by 37
First-line treatment of acute lymphoblastic leukemia with pegasparaginase
Pession, A. (2009) · Biologics · doi:10.2147/btt.s3295 · Cited by 37
Larson, N., Ray, A., Malugin, A., Pike, D. B., & Ghandehari, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0267-7 · Cited by 36
Tippayamontri, T., Kotb, R. R., Paquette, B., & Sanche, L. (2013) · PubMed · Cited by 33
Guo, J., O’Mahony, A., Cheng, W. P., & O’Driscoll, C. M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.050 · Cited by 32
Bae, Y., Buresh‐Stiemke, R. A., Williamson, T. P., Chen, T.-H. H., & Furgeson, D. Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.005 · Cited by 32
Ternary Polymeric Nanoparticles for Oral siRNA Delivery
Zhang, J., He, C., Tang, C., & Yin, C. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0961-8 · Cited by 31
Vavvas, D. G., & D’Amico, D. J. (2006) · PubMed · doi:10.1016/j.ohc.2006.05.008 · Cited by 30
Hughes, J. A., Yadava, P., & Mesaros, R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-360-2_31 · Cited by 30
RNA Interference from Biology to Therapeutics
Howard, K. A. (2012) · Advances in delivery science and technology · doi:10.1007/978-1-4614-4744-3 · Cited by 29
Zheng, S., Chang, S., Lu, J., Chen, Z., Li, X., Nie, Y., He, B., Shengquan, Z., & Gu, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021064 · Cited by 29
Antiangiogenic anticancer strategy based on nanoparticulate systems
Yoncheva, K., & Momekov, G. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.585155 · Cited by 28
Inactivation of harmful tumour-associated proteolysis by nanoparticulate system
Kos, J., Obermajer, N., Doljak, B., Kocbek, P., & Kristl, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.037 · Cited by 28
Beutel, G., Glen, H., Schöffski, P., Chick, J., Gill, S., Cassidy, J., & Twelves, C. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0104 · Cited by 28
Phase II study of NKTR-102 in women with platinum-resistant/refractory ovarian cancer.
Vergote, I. B., Micha, J. P., Pippitt, C. H., Rao, G. G., Spitz, D. L., Reed, N. S., Dark, G. G., Garcia, A., Maslyar, D. J., & Rustin, G. J. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.5013 · Cited by 27
Current Trends of Nanotechnology for Cancer Therapy
Anajwala, C. C., Jani, G. K., & Vijayendra Swamy, S. M. (2010) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2010.3.3.2 · Cited by 26
Polymeric micelles for siRNA delivery
Falamarzian, A., Xiong, X.-B., Uludag, H., & Lavasanifar, A. (2012) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(12)50004-3 · Cited by 25
BIOPHARMACEUTICS OF LIPOSOMAL INTERLEUKIN 2, ONCOLIPIN
Neville, M. E., Boni, L. T., Pflug, L. E., et al. (2000) · Cytokine · doi:10.1006/cyto.2000.0769 · Cited by 21
The Biological Basis of Cancer
Cogliano, V. J., Kappas, A., Voutsinas, G. E., & Zapponi, G. A. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4741-9_2 · Cited by 17
Polymeric Micelles for siRNA Delivery
Pittella, F., & Kataoka, K. (2012) · Advances in delivery science and technology · doi:10.1007/978-1-4614-4744-3_8 · Cited by 16
Progressing from Gene Mutations to Cancer
Fearon, E. R., & Bommer, G. T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50017-8 · Cited by 15
Bukowski, R. M., Young, J., Goodman, G. E., Meyers, F. J., Issell, B. F., Sergi, J. S., McLain, D., Fyfe, G., & Finke, J. H. (1993) · Investigational New Drugs · doi:10.1007/bf00874158 · Cited by 14
Nanoparticles for Cancer Diagnosis and Therapy
Wang, A. Z., Gu, F., & Farokhzad, O. C. (2008) · Nanostructure science and technology · doi:10.1007/978-0-387-78608-7_10 · Cited by 13
Guo, Z., Wheler, J. J., Naing, A., Mani, S., Goel, S., Mulcahy, M. F., Gamza, F., Longley, C. B., Buchbinder, A., & Kurzrock, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2556 · Cited by 13
Phase II trial of pegylated interferon and thalidomide in malignant metastatic melanoma
Vaishampayan, U. N., Heilbrun, L. K., Marsack, C., Smith, D. W., & Flaherty, L. E. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282eea391 · Cited by 11
Takagi, A. (2011) · Oncology Reports · doi:10.3892/or.2011.1465 · Cited by 11
New agents in the treatment of acute lymphocytic leukaemia
Thomas, D. A., Cortes, J. E., & Kantarjian, H. M. (2002) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2003.0234 · Cited by 8
Lancet, J. E., Cortes, J. E., Kovacsovics, T. J., Hogge, D. E., Kolitz, J. E., Tallman, M. S., Chiarella, M. T., Louie, A. C., & Feldman, E. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.6519 · Cited by 6
Mueller, C., Al-Batran, S. E., Jaeger, E., Bausch, M., Sethuraman, N., & Unger, C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.14040 · Cited by 2
Cited by
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
Liu, Y., Bhattarai, P., Dai, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00618k · Cited by 2,904
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Metadata
- Authors
- Pérez-Herrero, E., & Fernández-Medarde, A.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 93
- Pages
- 52-79
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2100173894
- Cited by
- 1,875
- References
- 518
- FWCI
- 34.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.